Author pages are created from data sourced from our academic publisher partnerships and public sources.
Rivastigmine for dementia associated with Parkinson's disease.
BACKGROUND Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such… Expand
Impact of the motor complications of Parkinson's disease on the quality of life.
- S. Chapuis, L. Ouchchane, O. Metz, L. Gerbaud, F. Durif
- Movement disorders : official journal of the…
- 1 February 2005
The impact of motor complications of Parkinson's disease (PD), especially levodopa-induced dyskinesias, on quality of life (QL) was studied in 143 patients with PD. All were evaluated on the Hoehn… Expand
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.
Pathogenic variants in the glucocerebrosidase gene (GBA) encoding the enzyme deficient in Gaucher's disease (GD) are associated with Parkinson's disease (PD). To investigate the sequence variants,… Expand
Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
Chronic bilateral subthalamic stimulation leads to a spectacular clinical improvement in patients with motor complications. However, the post-operative body weight gain involved may limit the… Expand
Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up
- M. Ulla, J. M. Bonny, L. Ouchchane, I. Rieu, B. Claise, F. Durif
- Biology, Medicine
- PloS one
- 1 March 2013
Purpose To study changes of iron content in basal ganglia in Parkinson’s disease (PD) through a three-year longitudinal follow-up of the effective transverse relaxation rate R2*, a validated MRI… Expand
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
We hypothesized that specific mutations in the β‐glucocerebrosidase gene (GBA) causing neuropathic Gaucher's disease (GD) in homozygotes lead to aggressive cognitive decline in heterozygous… Expand
Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE
Background The Natural History and Neuroprotection in Parkinson Plus Syndromes (NNIPPS) study was a large phase III randomized placebo-controlled trial of riluzole in Progressive Supranuclear Palsy… Expand
Repetitive Behaviours in Patients with Gilles de la Tourette Syndrome: Tics, Compulsions, or Both?
Background Repetitive behaviours (RB) in patients with Gilles de la Tourette syndrome (GTS) are frequent. However, a controversy persists whether they are manifestations of obssessive-compulsive… Expand
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder
- M. L. Fantini, L. Macedo, +11 authors F. Durif
- Journal of Neurology, Neurosurgery & Psychiatry
- 8 July 2014
Objective To assess the frequency of symptoms of impulse control disorders (ICD, namely pathological gambling, compulsive sexual behaviour, compulsive eating and compulsive shopping) and related… Expand
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Objective: To assess the role of age in the results of bilateral deep brain stimulation in the subthalamic nucleus (DBS-STN), we carried out a study of two groups of patients regarding age at time of… Expand